Exact Sciences CORP Form 4 insider transactions
Everett Cunningham, Chief Commercial Officer of Exact Sciences, reports acquisition and disposition of company stock, including shares from a performance share unit settlement and employee stock purchase plan.
James Herriott, SVP, General Counsel & Secretary of Exact Sciences Corp, reports acquisition and disposal of company stock.
Jeffrey Thomas Elliott, CFO of Exact Sciences, reports stock acquisitions and disposals, including shares from performance share units, employee stock purchase plan, and sales to cover withholding taxes.
Brian Baranick, EVP and GM of Precision Oncology at Exact Sciences, reports the acquisition and disposal of company stock related to performance share unit settlement and tax obligations.
Sarah Condella, EVP of Human Resources at Exact Sciences, reports stock acquisitions and disposals, including shares from performance share units, employee stock purchase plan, and sales to cover withholding taxes.
Jacob A. Orville, General Manager of Screening at Exact Sciences Corp, reports acquisition and disposal of company stock, including shares from performance share units and sales to cover withholding taxes.
Kevin Conroy, CEO of Exact Sciences, reports acquisition and disposal of company stock, including shares from a performance share unit settlement and sales to cover withholding taxes.
Sarah Condella, EVP of Human Resources at Exact Sciences, sold 2,000 shares of common stock at $70 per share on April 1, 2024, under a pre-arranged trading plan.
Brian Baranick, EVP, GM., Precision Oncology at Exact Sciences Corp, reported the sale of 924 shares of common stock at a price of $79.43 per share on April 2, 2024, under a pre-arranged 10b5-1 trading plan.
Sarah Condella, EVP of Human Resources at Exact Sciences, sold 2,000 shares of common stock at $70 per share on March 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Jacob Orville, General Manager of Screening at Exact Sciences Corp, reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
Director Daniel Levangie of Exact Sciences Corp. sold 5,000 shares of common stock on March 1, 2024, at a price of $57.50 per share.
James Herriott, General Counsel of Exact Sciences Corp, reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
Chief Financial Officer of Exact Sciences, Jeffrey Elliott, reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
Director James Edward Doyle sold 2,000 shares of Exact Sciences Corp. on March 1, 2024, at a price of $57.5 per share.
Everett Cunningham, Chief Commercial Officer of Exact Sciences, exercised stock options and sold shares to cover withholding taxes on February 29th and March 1st, 2024.
CEO Kevin Conroy reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
Sarah Condella, EVP of Human Resources at Exact Sciences, reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
Brian Baranick, General Manager of Precision Oncology at Exact Sciences, reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
General Manager of Screening at Exact Sciences Corp, Jacob Orville, reports stock transactions including vesting of restricted stock units and sales to cover withholding taxes.
James Herriott, General Counsel of Exact Sciences Corp, reports acquisition and disposal of common stock and restricted stock units.
Everett Cunningham, Chief Commercial Officer of Exact Sciences, reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
Jeffrey Thomas Elliott, CFO of Exact Sciences, reports stock transactions including vesting of restricted stock units, sales to cover taxes, and holdings in common stock and derivative securities.
CEO Kevin Conroy reports acquisition and disposal of Exact Sciences (EXAS) stock and restricted stock units.
Sarah Condella, EVP of Human Resources at Exact Sciences, reports the vesting of restricted stock units, subsequent sale of shares to cover taxes, and new grants of restricted stock units.
Brian Baranick, General Manager of Precision Oncology at Exact Sciences, reports the vesting of restricted stock units, subsequent sale of shares to cover taxes, and new grants of restricted stock units.